Adults with obesity in high-income countries now have blood-pressure and cholesterol levels far closer to those of their ...

The Food and Drug Administration has approved a powerful new kind of cholesterol-lowering drug. The Food and Drug Administration has approved a new kind of drug to cut cholesterol. So we've called up ...

High cholesterol is one of the most common and manageable risk factors for heart disease. Millions of adults are prescribed cholesterol-lowering drugs to reduce low-density lipoprotein (LDL) ...

The results of a phase three clinical trial for a cholesterol-lowering drug have shown that this drug, called enlicitide, can reduce the levels of low-density lipoprotein (LDL) cholesterol by 60% ...

Federal regulators approved a first-of-its-kind cholesterol medication from Merck that rivals the effectiveness of powerful ...

FDA-approved Lipfendra, the first oral PCSK9 inhibitor, which can cut LDL or "bad" cholesterol by nearly 60%.

Lipfendra (enlicitide) offers a convenient option for adults who haven’t been able to lower their cholesterol sufficiently with statins. The U.S. Food and Drug Administration (FDA) approved Lipfendra ...

Share on Pinterest A new study explores the cholesterol-lowering effects of a new drug called enlicitide. Nicole Mason/Stocksy A new study investigates the cholesterol-lowering effects of an ...

A massive genetic study found that naturally lower cholesterol is linked to a dramatically reduced risk of dementia. The research simulated the effects of cholesterol-lowering drugs and showed up to ...

Altering a single gene may help people lower dangerously high levels of cholesterol and other fats in the blood, according to new research presented Saturday at the annual meeting of the American ...